Texas Oncology Consolidates Its Fort Worth Presence With A New, 100,000 SF Facility

Texas Oncology has opened a new facility in Fort Worth’s medical district. The new place is a consolidation of three other Texas Oncology locations within the city and brings medical, gynecologic, and radiation oncology services under one roof, the organization says. A bit more: Texas Oncology occupies three of the four floors of the new 100,000 square foot building at 500 South Henderson Street, developed by Cambridge Holdings, Inc. The project includes an adjacent parking garage with free parking for patients and caregivers. With construction of the larger center concluded this summer, Texas Oncology followed through on plans to consolidate… Full Story

Amid News That Others Like It Have Struggled, DFW’s Lone Proton Therapy Center Says It’s Viable, With Room For Growth

Coming up on three years since it first started treating patients, the Texas Center for Proton Therapy has administered proton beam therapy to 1,000 people. It’s a rate that’s kept the $105 million facility financially viable, even as it seeks to take on higher volumes moving forward, the center says. “I think patient volumes have been pretty consistent with what I was expecting coming in,” says Dr. Andrew Lee, who heads the facility. “This is not my first proton center. Just personally, I’ve been very pleased and honored to be part of the team that’s brought proton therapy to the… Full Story

Texas Oncology Receives Recognition For Care Management Strategies

Another oncology tidbit today, as Texas Oncology announced it’s been awarded a 2018 Pharmacy Benefit Management Institute Excellence Award. The recognition has to do with Texas Oncology’s care management strategies, and with its success in raising adherence to oncology meds to 96 percent, whereas the national average sits around 70 percent. Oral chemotherapy, Texas Oncology says, is taking on a greater importance in cancer care with more and more drugs being introduced to the market. “A medically integrated care approach with physicians, nurses, pharmacists, nutritionists, and financial counselors working together improves patient experiences and compliance while reducing costs from less waste,… Full Story

Baylor University Medical Center, Texas Oncology Introduce Car-T Therapy

Baylor University Medical Center and Texas Oncology are the first in North Texas to offer one of the two FDA-approved CAR-T cell therapies. The specific treatment, known as Yescarta, is geared toward diffuse large B-cell lymphoma. CAR-T (Chimeric Antigen Receptor T cell therapy) is a cancer treatment in which a patient’s immune cells are removed from the body, genetically re-engineered, and then put back into the body so that they can attack the cancer. At BUMC, it will be used on adult patients who have not responded to other treatments or who have relapsed after two other kinds of treatment,… Full Story